WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 29.39%576.86M | -24.56%480.2M | -43.11%374.65M | -64.03%390.49M | -49.38%445.82M | -38.73%636.57M | -44.01%658.54M | 153.63%1.09B | 61.90%880.72M | 106.57%1.04B |
Transactional financial assets | --658.08K | ---- | ---- | --2.88M | ---- | ---- | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | 69.31%73.04M | 21.48%69.97M | -53.21%43.32M | -58.22%42.29M | -61.77%43.14M | -59.23%57.6M | -26.39%92.57M | -4.96%101.23M | 5.98%112.83M | -9.69%141.27M |
-Notes receivable | --5.51M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts receivable | 56.52%67.53M | 21.48%69.97M | -53.21%43.32M | -58.22%42.29M | -61.77%43.14M | -59.23%57.6M | -26.39%92.57M | -4.96%101.23M | 5.98%112.83M | -9.69%141.27M |
Other receivables (including interest and dividends) | 15.64%12.34M | 3.09%18.53M | -14.48%14.32M | -36.40%14.8M | -54.47%10.67M | 18.40%17.97M | -7.59%16.74M | -4.71%23.26M | 8.91%23.44M | -59.97%15.18M |
-Other receivable | 15.64%12.34M | ---- | -14.48%14.32M | ---- | -54.47%10.67M | ---- | -7.59%16.74M | ---- | 8.91%23.44M | ---- |
Advance payment | 19.94%77.74M | 2.03%90.48M | 16.30%86.54M | 32.87%92.92M | -12.64%64.82M | -11.04%88.68M | -30.21%74.41M | -33.20%69.93M | -27.56%74.2M | 10.64%99.68M |
Inventories | 36.63%2.09B | 36.51%2.12B | 38.85%1.96B | 15.13%1.71B | 6.39%1.53B | 9.79%1.55B | 13.72%1.41B | 23.05%1.49B | 8.55%1.44B | 12.41%1.41B |
Receivable financing | 338.74%18.21M | -24.22%1.33M | ---- | --2.8M | 1,704.34%4.15M | -85.19%1.75M | -34.63%228.81K | ---- | -98.37%230K | 55.77%11.84M |
Other current assets | 11.13%12.5M | 14.81%10.2M | 55.30%8.88M | 246.80%7.92M | 574.38%11.25M | 833.65%8.89M | 113.42%5.72M | 41.73%2.28M | -30.14%1.67M | -21.02%951.68K |
Total current assets | 35.64%2.86B | 18.03%2.79B | 10.06%2.49B | -18.19%2.26B | -16.63%2.11B | -13.15%2.36B | -15.41%2.26B | 47.56%2.77B | 19.63%2.53B | 32.07%2.72B |
Non Current assets | ||||||||||
Other equity investment | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M | 0.00%13.51M |
Other non-current financial assets | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | 0.00%600K | -81.36%600K |
Investment real estate | ---- | ---- | ---- | ---- | ---- | --7.09M | ---- | ---- | ---- | ---- |
Long-term equity investment | --9.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Long term receivable account | 29.44%23.28M | 77.95%26.51M | 13.67%16.51M | 14.52%16.23M | 30.72%17.99M | -29.45%14.9M | -28.89%14.52M | 6.53%14.18M | 93.56%13.76M | --21.11M |
Fixed assets | -1.21%3.71B | ---- | 74.68%3.63B | ---- | 94.85%3.75B | ---- | 15.26%2.08B | ---- | 9.81%1.93B | ---- |
Constru in process | 12.08%395.6M | ---- | -66.82%456.49M | ---- | -68.20%352.98M | ---- | 44.10%1.38B | ---- | 31.05%1.11B | ---- |
Productive biological assets | 47.29%568.8M | 28.01%530.97M | 5.15%467.63M | -17.14%377.09M | -11.98%386.18M | 5.62%414.79M | 22.55%444.71M | 87.47%455.1M | 89.56%438.74M | 55.56%392.72M |
Intangible assets | -11.35%87.82M | -7.90%93.39M | -8.89%94.76M | -8.22%96.66M | -7.86%99.07M | -7.40%101.39M | -6.62%104.01M | -7.22%105.32M | -4.04%107.51M | -2.37%109.49M |
Goodwill | -0.09%580.6M | -4.78%580.74M | -4.78%580.86M | -4.79%580.99M | -4.79%581.12M | -0.12%609.87M | -0.12%610.04M | -0.13%610.19M | -0.14%610.36M | -0.14%610.58M |
Long deferred expense | 193.40%13.95M | 62.98%9.54M | 86.44%8.71M | -2.15%7.44M | -41.45%4.75M | -34.31%5.85M | -48.47%4.67M | -21.48%7.6M | -11.83%8.12M | 33.47%8.91M |
Deferred tax assets | 7.04%44.95M | -19.62%46.76M | -21.84%41.93M | -12.60%42.04M | -3.30%41.99M | 44.82%58.17M | 46.29%53.65M | 45.92%48.1M | 31.65%43.42M | 17.78%40.17M |
Usufruct assets | 25.67%418.26M | -1.31%330.08M | -3.74%313.72M | -2.94%322.62M | 0.33%332.83M | 8.53%334.47M | 16.90%325.9M | 39.10%332.37M | 56.88%331.73M | 56.27%308.18M |
Other non current assets | 39.27%34.96M | -68.21%35.35M | -81.50%26.05M | -66.71%48.31M | -78.60%25.1M | 7.71%111.19M | 0.46%140.79M | 66.25%145.13M | 72.41%117.29M | 60.06%103.23M |
Total non current assets | 5.18%5.9B | 8.07%5.74B | 9.35%5.65B | 15.05%5.6B | 18.81%5.61B | 18.86%5.31B | 18.98%5.16B | 19.84%4.87B | 21.10%4.72B | 24.88%4.47B |
Total assets | 13.51%8.76B | 11.14%8.53B | 9.57%8.13B | 3.00%7.86B | 6.44%7.72B | 6.74%7.67B | 5.89%7.42B | 28.60%7.63B | 20.58%7.25B | 27.51%7.19B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -8.23%1.06B | -18.11%895.13M | 19.49%1.14B | 39.69%1.19B | 124.90%1.15B | 60.02%1.09B | 36.16%954.78M | 14.53%854.72M | -28.19%512.8M | -6.92%683.06M |
Notes payable and accounts payable | 41.22%571.34M | 49.69%618.45M | 60.28%675.1M | -15.75%492.09M | 1.40%404.56M | -8.38%413.14M | -0.80%421.2M | 22.46%584.11M | -11.86%398.98M | -8.30%450.93M |
-Notes payable | 67.24%222.43M | 73.25%199.23M | 63.44%186.32M | 13.52%129.41M | 56.47%133M | 0.88%115M | 0.00%114M | 42.09%114M | 8.77%85M | 71.01%114M |
-Accounts payable | 28.48%348.91M | 40.61%419.21M | 59.11%488.78M | -22.85%362.68M | -13.51%271.56M | -11.51%298.14M | -1.09%307.2M | 18.49%470.11M | -16.17%313.98M | -20.74%336.93M |
Contract liabilities | -6.81%19.26M | 2.23%26.9M | -8.16%30.08M | -48.64%18.99M | 6.19%20.67M | -34.46%26.31M | 4.74%32.75M | -11.66%36.97M | -16.16%19.47M | 93.48%40.15M |
Salaries payable | 61.70%107.85M | 34.81%48.78M | 20.67%43.51M | -41.32%69.3M | -43.74%66.7M | 20.50%36.18M | 35.57%36.05M | 316.92%118.09M | 267.67%118.56M | 4.81%30.03M |
Taxs payable | 1.37%7.91M | 18.91%9.65M | 15.86%6.93M | 26.40%8.29M | 23.05%7.8M | -0.19%8.12M | -7.18%5.98M | -34.96%6.56M | -47.52%6.34M | -23.93%8.14M |
Other payable (including interest and dividends) | 21.30%845.74M | 69.50%697.01M | 44.77%605.35M | 99.21%604.77M | 90.33%697.23M | 37.74%411.21M | 29.42%418.13M | -10.51%303.58M | -2.45%366.33M | 30.65%298.54M |
-Dividend payable | ---- | ---- | -94.60%980K | ---- | ---- | ---- | --18.16M | ---- | ---- | ---- |
-Other payable | 21.30%845.74M | ---- | 51.10%604.37M | ---- | 90.33%697.23M | ---- | 23.80%399.98M | ---- | -2.45%366.33M | ---- |
Non current liabilities due within one year | 120.41%892.36M | 52.45%822.89M | 70.23%816.18M | -25.03%430.61M | -47.82%404.86M | 0.76%539.78M | 102.14%479.46M | 268.42%574.41M | 615.65%775.86M | 376.55%535.73M |
Other current liabilities | 148.19%50.34M | 19,925.49%50.24M | 7,208.15%20.36M | 10,536.98%20.3M | 9,789.11%20.28M | -33.23%250.89K | 51.35%278.56K | 1.36%190.81K | 55.87%205.12K | 42.25%375.78K |
Total current liabilities | 28.02%3.55B | 25.36%3.17B | 42.14%3.34B | 14.51%2.84B | 26.24%2.78B | 23.50%2.53B | 34.17%2.35B | 37.79%2.48B | 27.94%2.2B | 25.82%2.05B |
Current liabilities | ||||||||||
Long term loan | -26.67%451.22M | -23.74%532.32M | -40.56%395.86M | 42.47%820.84M | 173.89%615.35M | 28.86%698.07M | -19.25%665.98M | -26.36%576.16M | -67.40%224.67M | 15.43%541.71M |
Bonds payable | 4.33%780.51M | -4.52%768.59M | -4.44%757.82M | -4.30%747.81M | -2.84%748.15M | 6.15%805M | 6.21%793.07M | --781.41M | --770.05M | --758.39M |
Long term account payable | 47.04%348.22M | ---- | 666.82%333.11M | ---- | 131.85%236.83M | ---- | -76.77%43.44M | ---- | -13.93%102.15M | ---- |
Estimate liabilities | 8.74%6.03M | 5.97%4.73M | 1.90%4.45M | -17.41%4.66M | 0.39%5.55M | 5.36%4.46M | 2.16%4.37M | 29.96%5.65M | 29.40%5.53M | -19.64%4.24M |
Deferred tax liabilities | -10.96%4.23M | -11.12%4.37M | -9.95%4.58M | -11.67%4.63M | -12.05%4.76M | -12.56%4.91M | -12.80%5.08M | -12.89%5.24M | -13.36%5.41M | -13.24%5.62M |
Long term deferred income | 14.71%17.17M | -2.54%14.87M | 0.43%15.51M | -0.47%15.76M | 5.98%14.97M | 7.23%15.26M | 11.14%15.44M | 22.50%15.83M | 9.07%14.13M | 12.72%14.23M |
Lease liabilities | 20.30%264.96M | -1.87%218.5M | -2.93%212.7M | -13.11%187.02M | -1.29%220.25M | 3.52%222.66M | 13.57%219.1M | 31.82%215.23M | 61.37%223.13M | 81.95%215.09M |
Total non current liabilities | 1.44%1.87B | 11.17%2.02B | -1.29%1.72B | 24.09%2.05B | 37.23%1.85B | 7.27%1.81B | -11.59%1.75B | 47.78%1.65B | 38.71%1.35B | 128.60%1.69B |
Total liabilities | 17.40%5.43B | 19.43%5.19B | 23.62%5.06B | 18.34%4.89B | 30.41%4.62B | 16.16%4.34B | 9.91%4.1B | 41.62%4.13B | 31.83%3.54B | 57.96%3.74B |
Shareholders equity | ||||||||||
Paid-in capital | 0.12%510.07M | 0.78%510.07M | 0.78%510.07M | 0.78%510.03M | 0.66%509.45M | 0.00%506.1M | 0.00%506.1M | 0.00%506.1M | 0.00%506.09M | 0.00%506.09M |
Other equity instruments | -1.72%224.55M | -10.00%224.55M | -10.00%224.56M | -9.91%224.81M | -8.45%228.47M | -0.02%249.51M | -0.02%249.52M | --249.54M | --249.56M | --249.57M |
Capital reserve funds | 0.73%2.3B | 4.68%2.3B | 4.68%2.3B | 4.06%2.3B | 3.38%2.29B | -0.54%2.2B | -0.54%2.2B | 0.01%2.21B | 0.00%2.21B | 0.00%2.21B |
Surplus reserve funds | 47.36%54.69M | 3.90%37.12M | 3.90%37.12M | 3.90%37.12M | 3.90%37.12M | 5.76%35.72M | 5.76%35.72M | 5.76%35.72M | 5.76%35.72M | 23.15%33.78M |
Retained profit | 4,852.36%511.29M | -14.14%269.81M | -111.18%-34.52M | -127.31%-127.72M | -98.47%10.32M | -25.23%314.24M | 21.96%308.69M | 101.35%467.63M | 23.89%673.21M | -14.82%420.26M |
Less:Treasury stock | --297.16M | --34.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other composite income | -65.95%-4.7M | 47.63%-2.84M | 21.52%-3.23M | 18.13%-3.85M | 25.05%-2.83M | -17.05%-5.42M | 14.14%-4.11M | -44.39%-4.7M | 19.73%-3.78M | -1.29%-4.63M |
Shareholders equity without minority interests | 7.59%3.3B | 0.22%3.31B | -7.86%3.04B | -15.13%2.94B | -16.44%3.07B | -3.42%3.3B | 1.42%3.29B | 16.30%3.46B | 11.62%3.67B | 5.66%3.42B |
Minority interests | 18.36%38.07M | 11.99%37.37M | 5.02%34.68M | -13.13%32.46M | -17.78%32.16M | -7.56%33.37M | -7.76%33.02M | -5.60%37.37M | 0.83%39.12M | -8.32%36.1M |
Total shareholder equity | 7.71%3.34B | 0.34%3.34B | -7.73%3.07B | -15.11%2.97B | -16.46%3.1B | -3.47%3.33B | 1.32%3.33B | 16.01%3.5B | 11.50%3.71B | 5.49%3.45B |
Total liabilityies and equity | 13.51%8.76B | 11.14%8.53B | 9.57%8.13B | 3.00%7.86B | 6.44%7.72B | 6.74%7.67B | 5.89%7.42B | 28.60%7.63B | 20.58%7.25B | 27.51%7.19B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.